Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion
NYSE:WST

West Pharmaceutical Services (WST) Stock Price, News & Analysis

West Pharmaceutical Services logo
$392.00 -2.03 (-0.52%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$396.52 +4.53 (+1.16%)
As of 10/23/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About West Pharmaceutical Services Stock (NYSE:WST)

Advanced

Key Stats

Today's Range
$389.72
▼
$394.18
50-Day Range
$337.66
▼
$394.30
52-Week Range
$223.83
▼
$397.15
Volume
718,047 shs
Average Volume
499,428 shs
Market Capitalization
$27.59 billion
P/E Ratio
50.19
Dividend Yield
0.22%
Price Target
$391.17
Consensus Rating
Moderate Buy

Company Overview

West Pharmaceutical Services, Inc. develops and manufactures components and delivery systems used in the administration and packaging of injectable medicines and other healthcare products. Its offerings include elastomer closures, seals, syringe components, drug-delivery systems, and other specialized packaging components designed to support the safety, quality, and performance of pharmaceutical products.

The company also provides contract-manufacturing services for pharmaceutical, biotechnology, and medical-device customers. These services include the production and assembly of proprietary healthcare products, including components and systems used in drug delivery, diagnostic applications, and other medical technologies.

Founded in 1923 by Herman O. West, the company is headquartered in Exton, Pennsylvania. West Pharmaceutical Services serves customers worldwide through operations and facilities in North America, Europe, and Asia-Pacific. Its products are used by pharmaceutical and biotechnology companies, healthcare manufacturers, and other organizations involved in the development and delivery of medicines.

AI Generated. May Contain Errors.

West Pharmaceutical Services Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
78th Percentile Overall Score

WST MarketRank™: 
3.890155579395 of 5 stars

West Pharmaceutical Services scored higher than 78% of companies evaluated by MarketBeat, and ranked 125th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    West Pharmaceutical Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on no strong buy ratings, 12 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for West Pharmaceutical Services is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    West Pharmaceutical Services has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about West Pharmaceutical Services' stock forecast and price target.
  • Earnings Growth

    Earnings for West Pharmaceutical Services are expected to grow by 10.43% in the coming year, from $8.92 to $9.85 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of West Pharmaceutical Services is 50.19, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.38.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of West Pharmaceutical Services is 50.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.33.

  • Price to Earnings Growth Ratio

    West Pharmaceutical Services has a PEG Ratio of 2.75. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    West Pharmaceutical Services has a P/B Ratio of 8.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about West Pharmaceutical Services' valuation and earnings.
  • Percentage of Shares Shorted

    3.00% of the float of West Pharmaceutical Services has been sold short.
  • Short Interest Ratio / Days to Cover

    West Pharmaceutical Services has a short interest ratio ("days to cover") of 3.11, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in West Pharmaceutical Services has recently decreased by 11.65%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    West Pharmaceutical Services has a dividend yield of 0.22%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    West Pharmaceutical Services does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of West Pharmaceutical Services is 11.27%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 8.93% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.

  • Read more about West Pharmaceutical Services' dividend.
  • News Sentiment

    West Pharmaceutical Services has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for West Pharmaceutical Services this week, compared to 5 articles on an average week.
  • Search Interest

    9 people have searched for WST on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added West Pharmaceutical Services to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, West Pharmaceutical Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,443,749.00 in company stock.

  • Percentage Held by Insiders

    0.60% of the stock of West Pharmaceutical Services is held by insiders.

  • Percentage Held by Institutions

    93.90% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about West Pharmaceutical Services' insider trading history.
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WST Stock News Headlines

West Pharmaceutical Services (WST) Projected to Release Earnings on Thursday
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
West Declares Quarterly Dividend
See More Headlines

WST Stock Analysis - Frequently Asked Questions

West Pharmaceutical Services' stock was trading at $275.53 at the beginning of the year. Since then, WST shares have increased by 42.3% and is now trading at $391.9970.

West Pharmaceutical Services, Inc. (NYSE:WST) announced its earnings results on Thursday, July, 23rd. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.29. The firm's quarterly revenue was up 13.8% compared to the same quarter last year.
Read the conference call transcript
.

West Pharmaceutical Services' board authorized a stock buyback plan on Tuesday, February 17th 2026, which permits the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 5.6% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's leadership believes its stock is undervalued.

West Pharmaceutical Services subsidiaries include these companies: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., The Tech Group Inc., Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), TGPR Holdings Limited, WD SG Pte. Ltd., and others.

West Pharmaceutical Services' top institutional investors include Vest Financial LLC (0.21%), AMI Asset Management Corp (0.20%), Robeco Institutional Asset Management B.V. (0.06%) and Nisa Investment Advisors LLC (0.05%). Insiders that own company stock include Eric Mark Green, Thomas W Hofmann, Annette F Favorite, Silji Abraham, Chad Winters and Charles Witherspoon.
View institutional ownership trends
.

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that West Pharmaceutical Services investors own include NVIDIA (NVDA), PayPal (PYPL), AbbVie (ABBV), Tesla (TSLA), Walmart (WMT), Johnson & Johnson (JNJ) and Home Depot (HD).

Company Calendar

Last Earnings
7/23/2026
Record date for 8/5 Dividend
7/29/2026
Ex-Dividend for 8/5 Dividend
7/29/2026
Dividend Payable
8/05/2026
Today
10/25/2026
Next Earnings (Estimated)
10/29/2026
Ex-Dividend for 11/18 Dividend
11/10/2026
Record date for 11/18 Dividend
11/11/2026
Dividend Payable
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NYSE:WST
CIK
105770
Employees
10,800
Year Founded
1923

Price Target and Rating

High Price Target
$447.00
Low Price Target
$295.00
Potential Upside/Downside
-0.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$7.81
Trailing P/E Ratio
50.19
Forward P/E Ratio
43.95
P/E Growth
2.75
Net Income
$493.70 million
Net Margins
16.98%
Pretax Margin
20.85%
Return on Equity
20.11%
Return on Assets
14.83%

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
2.82
Quick Ratio
2.12

Sales & Book Value

Annual Sales
$3.07 billion
Price / Sales
8.97
Cash Flow
$9.73 per share
Price / Cash Flow
40.27
Book Value
$44.10 per share
Price / Book
8.89

Miscellaneous

Outstanding Shares
70,380,000
Free Float
69,954,000
Market Cap
$27.59 billion
Optionable
Optionable
Beta
1.13

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:WST) was last updated on 10/23/2026 by MarketBeat.com Staff.
From Our Partners